<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04277728</url>
  </required_header>
  <id_info>
    <org_study_id>100001</org_study_id>
    <nct_id>NCT04277728</nct_id>
  </id_info>
  <brief_title>Hypoperfusion-hypodensity Mismatch for the Identification of Patients With Stroke Within 4.5 Hours</brief_title>
  <acronym>MissPerfeCT</acronym>
  <official_title>Mismatch Between Hypoperfusion and Hypodensity on CT for the Identification of Patients With Stroke Onset Within 4.5 Hours</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intravenous thrombolysis is recommended within 4.5 hours of stroke onset. The aim of the
      study is to evaluate whether a hypodensity on native CT within the virtually entire area of
      hypoperfusion on perfusion CT, i.e. hypoperfusion-hypodensity mismatch, identifies patients
      within the time window of thrombolysis in a multicenter cohort. The investigators hypothesize
      hypoperfusion-hypodensity mismatch will identify patients ≤ 4,5 hours of symptom onset with
      &gt;70% specificity and &gt;85% positive predictive value.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Positive predictive value of &quot;hypoperfusion hypodensity mismatch&quot; for the identification of patients ≤4.5 hours</measure>
    <time_frame>on admission</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of &quot;hypoperfusion hypodensity mismatch&quot; for the identification of patients ≤4.5 hours</measure>
    <time_frame>on admission</time_frame>
  </primary_outcome>
  <enrollment type="Actual">689</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>hypoperfusion-hypodensity mismatch</intervention_name>
    <description>hypoperfusion-hypodensity mismatch on computed tomography</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute ischemic stroke and known time of symptom onset.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute ischemic stroke

          -  evidence of acute intracranial vessel occlusion (any supratentorial proximal or
             peripheral artery of the anterior cerebral artery, middle cerebral artery or posterior
             cerebral artery territory) by CT hyper dense thrombus and/or CTangiography vessel
             occlusion and/or by ischemic perfusion deficit

          -  evidence for acute ischemic perfusion deficit, i.e. acute symptoms attributable to
             ischemic CT perfusion lesion

          -  complete native CT and CTperfusion performed on admission

          -  sufficient CT and CTperfusion quality for judgement of acute ischemic hypodensity

          -  known time of symptom onset.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Minnerup, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Muenster</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Münster</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

